DEA's Long-Awaited Virtual SUD Prescribing Proposal Hangs in the Balance With New Administration
Joelle Wilson, Shareholder in our Health Care Operations Group, joins Behavioral Health Business to discuss the latest DEA telehealth rule, its potential benefits for the SUD industry, and how it could disrupt the sector.